CDK5RAP3 and cancer: Previous studies demonstrated that CDK5RAP3 overexpression can partially antagonize the role of the checkpoint kinase 1 and 2 (Chk1/2), a G2/M DNA damage checkpoint, and promote the CDK1/cyclinB1 complex activation, thereby enabling cancer cells susceptible to DNA damage agents and inducing apoptosis (6, 39).